1-5 of 5
Kamila Czene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts

Arian Lundberg, Linda S. Lindström, J. Chuck Harrell, Claudette Falato, Joseph W. Carlson, Paul K. Wright, Theodoros Foukakis, Charles M. Perou, Kamila Czene, Jonas Bergh, Nicholas P. Tobin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7512–7520.
https://doi.org/10.1158/1078-0432.CCR-17-1535
Published: 14 December 2017
View article titled, Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts
Open the PDF for Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts in another window
Includes: Supplementary data
Journal Articles

PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients

Nicholas P. Tobin, Arian Lundberg, Linda S. Lindström, J. Chuck Harrell, Theodoros Foukakis, Lena Carlsson, Zakaria Einbeigi, Barbro K. Linderholm, Niklas Loman, Martin Malmberg, Mårten Fernö, Kamila Czene, Charles M. Perou, Jonas Bergh, Thomas Hatschek
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23): 7225–7231.
https://doi.org/10.1158/1078-0432.CCR-17-2301
Published: 30 November 2017
View article titled, PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients
Open the PDF for PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes

Jingmei Li, Emma Ivansson, Daniel Klevebring, Nicholas P. Tobin, Linda Sofie Lindström, Johanna Holm, Gabriela Prochazka, Camilla Cristando, Juni Palmgren, Sven Törnberg, Keith Humphreys, Johan Hartman, Jan Frisell, Mattias Rantalainen, Johan Lindberg, Per Hall, Jonas Bergh, Henrik Grönberg, Kamila Czene
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (10): 2584–2592.
https://doi.org/10.1158/1078-0432.CCR-16-0967
Published: 14 May 2017
View article titled, Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes
Open the PDF for Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes in another window
Includes: Supplementary data
Journal Articles

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients

Judith S. Brand, Elham Hedayati, Keith Humphreys, Jonas F. Ludvigsson, Anna L.V. Johansson, Jonas Bergh, Per Hall, Kamila Czene
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5249–5255.
https://doi.org/10.1158/1078-0432.CCR-16-1110
Published: 31 October 2016
View article titled, Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients
Open the PDF for Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

BRAF Mutations in Metastatic Melanoma: A Possible Association with Clinical Outcome

Rajiv Kumar, Sabrina Angelini, Kamila Czene, Ilari Sauroja, Marjo Hahka-Kemppinen, Seppo Pyrhönen, Kari Hemminki
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3362–3368.
Published: 05 September 2003
View article titled, <em>BRAF</em> Mutations in Metastatic Melanoma: <subtitle>A Possible Association with Clinical Outcome</subtitle>
Open the PDF for <em>BRAF</em> Mutations in Metastatic Melanoma: <subtitle>A Possible Association with Clinical Outcome</subtitle> in another window